Adult Hepatocellular Carcinoma Completed Phase 1 Trials for Dasatinib (DB01254)

Also known as: Hepatocellular Carcinoma, Adult / Adult hepatocellular carcinoma (disorder)

IndicationStatusPhase
DBCOND0040123 (Adult Hepatocellular Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00608361Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryTreatment